USPTO Patent Grant for Polypeptide Reagent Kit
Summary
The USPTO has granted a patent (US12578329B2) to Shimadzu Corporation for a reagent kit containing polypeptides designed for detecting intermolecular interactions. The patent details specific amino acid sequences and their modifications for use in this kit.
What changed
The United States Patent and Trademark Office (USPTO) has issued patent US12578329B2 to Shimadzu Corporation. This patent covers a reagent kit that includes a first and second polypeptide, each comprising specific amino acid sequences derived from SEQ ID NO: 1, with defined deletions and potential substitutions. The kit is designed for the detection of intermolecular interactions.
This grant represents a new intellectual property right for Shimadzu Corporation in the field of biotechnology and diagnostics. While patents do not impose direct regulatory obligations on other entities, they establish exclusive rights that may impact market entry, product development, and licensing strategies for companies operating in the pharmaceutical and biotechnology sectors. Compliance officers should be aware of this patent's existence as it pertains to research and development activities involving similar polypeptide reagents.
Archived snapshot
Mar 22, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
Reagent kit containing polypeptide for use in detection of intermolecular interactions
Grant US12578329B2 Kind: B2 Mar 17, 2026
Assignee
SHIMADZU CORPORATION
Inventors
Yuki Ohmuro
Abstract
A reagent kit comprising a first polypeptide including a part in any one of amino acid sequences (A) to (C), and a second polypeptide including a part in any one of amino acid sequences (A) to (C), which are consistent of different sequences from a sequence of the first polypeptide;
(A) an amino acid sequence in SEQ ID NO: 1 with deletion of an amino acid sequence from position 1 to 69 and an amino acid sequence from position 204 to 221,(B) an amino acid sequence in SEQ ID NO: 1 with deletion of an amino acid sequence from position 1 to 69 and deletion or substitution of at least one of amino acid residues at positions 146 to 156,(C) the amino acid sequence (A) or (B) with further deletion of at least one of amino acid residues at positions 70 to 74.
CPC Classifications
G01N 33/535 G01N 21/763 G01N 33/543 C07K 19/00 C07K 2319/01 C12N 5/10 C12N 9/0069 C12N 15/09 C12Q 1/26
Filing Date
2022-05-19
Application No.
17748727
Claims
4
Named provisions
Related changes
Get daily alerts for USPTO Patent Grants - Peptides (C07K)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from USPTO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when USPTO Patent Grants - Peptides (C07K) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.